Alberto Bosi

Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.

A. Bosi, A. Vannucchi, R. Saccardi, 1996, Haematologica.

Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment

C. Crescioli, A. Bosi, M. Amato, 2008, Journal of Neuroimmunology.

Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.

A. Vannucchi, S. Guidi, A. Zoccolante, 1996 .

Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals.

A. Bosi, F. Mazzotta, A. Azzi, 1996, Journal of neurovirology.

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation.

J. Snowden, P. Dreger, A. Bosi, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study.

A. Bosi, A. Vannucchi, R. Saccardi, 1993, Journal of chemotherapy.

Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study.

A. Bosi, A. Vannucchi, R. Saccardi, 1992, Journal of chemotherapy.

Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF.

A. Bosi, A. Vannucchi, R. Saccardi, 1995, Haematologica.

[The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases].

M. Cerinic, A. Bosi, M. Matucci Cerinic, 2011, Reumatismo.